Ebanga
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
71655-578 -
Package NDC
71655-578-03 -
Package NDC
71655-578-04 -
Package NDC
71655-578-08 -
Application number
BLA761172 -
SPL ID
58f2d4af-2a78-c5f5-e063-6294a90a36bb -
SPL set ID
de220c8f-ffcb-4522-a6a2-c7d6ce5de1b5 -
UNII
TG8IQ19NG2 -
RxCUI
2472156 -
RxCUI
2472161
What the source publishes
- Labeler
- Emergent BioDefense Operations Lansing LLC
- Active ingredients
- Ansuvimab
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Ebanga",
"splId": "58f2d4af-2a78-c5f5-e063-6294a90a36bb",
"labels": [
{
"setId": "de220c8f-ffcb-4522-a6a2-c7d6ce5de1b5",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=de220c8f-ffcb-4522-a6a2-c7d6ce5de1b5",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=de220c8f-ffcb-4522-a6a2-c7d6ce5de1b5"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "Emergent BioDefense Operations Lansing LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 CARTON in 1 BOX (71655-578-03) / 36 VIAL, GLASS in 1 CARTON (71655-578-02) / 8 mL in 1 VIAL, GLASS (71655-578-01)",
"package_ndc": "71655-578-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20201221"
},
{
"sample": false,
"description": "4 CARTON in 1 BOX (71655-578-04) / 36 VIAL, GLASS in 1 CARTON (71655-578-02) / 8 mL in 1 VIAL, GLASS (71655-578-01)",
"package_ndc": "71655-578-04",
"identifierStatus": "well-formed",
"marketing_start_date": "20201221"
},
{
"sample": false,
"description": "8 CARTON in 1 BOX (71655-578-08) / 36 VIAL, GLASS in 1 CARTON (71655-578-02) / 8 mL in 1 VIAL, GLASS (71655-578-01)",
"package_ndc": "71655-578-08",
"identifierStatus": "well-formed",
"marketing_start_date": "20201221"
}
],
"productId": "71655-578_58f2d4af-2a78-c5f5-e063-6294a90a36bb",
"useDomain": "unknown",
"dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"productNdc": "71655-578",
"deaSchedule": null,
"genericName": "Ansuvimab",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ANSUVIMAB",
"strength": "400 mg/8mL"
}
],
"applicationNumber": "BLA761172",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20201221",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000194038",
"N0000194037"
],
"unii": [
"TG8IQ19NG2"
],
"rxcui": [
"2472156",
"2472161"
],
"spl_set_id": [
"de220c8f-ffcb-4522-a6a2-c7d6ce5de1b5"
],
"pharm_class_epc": [
"Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]"
],
"pharm_class_moa": [
"Zaire Ebolavirus Glycoprotein-directed Antibody Interactions [MoA]"
],
"manufacturer_name": [
"Emergent BioDefense Operations Lansing LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:71655-578_58f2d4af-2a78-c5f5-e063-6294a90a36bb"